MedTrace Logo

Clinical Trial of Vit D and Calcium for Recurrent BPPV

NCT05863949 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 860

Last updated 2025-06-25

No results posted yet for this study

Summary

Randomized double blind placebo controlled trial of vitamin D supplements, with or without calcium supplementation, versus placebo in reduction of recurrences in BPPV.

Conditions

  • BPPV
  • Benign Paroxysmal Positional Vertigo
  • Vertigo
  • Vertigo, Peripheral
  • Dizziness
  • Dizziness; Epidemic
  • Vitamin D Deficiency
  • Calcium Deficiency

Interventions

DIETARY_SUPPLEMENT

vitamin D +/- calcium

vitamin D 1000iU daily +/- calcium 500mg BID daily

OTHER

Placebo

placebo pill x3 daily

Sponsors & Collaborators

  • Ottawa Hospital Research Institute

    lead OTHER

Principal Investigators

  • Darren Tse, MD · Ottawa Hospita Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2026-09-30
Completion
2026-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05863949 on ClinicalTrials.gov